Bioactive Compounds
-
A4171 EPZ0056872 CitationTarget: EZH2Summary: EZH2 inhibitor,potent and selective -
A4040 Atazanavir sulfate (BMS-232632-05)Summary: Protease inhibitor -
A4115 JNJ-77066211 CitationTarget: Cyclin-Dependent Kinases|Aurora KinasesSummary: Potent CDK/Aurora kinase inhibitor -
A4208 NSC 319726Target: p53Summary: Reactivator of mutant p53 -
A4212 Pomalidomide (CC-4047)Summary: Immunomodulator,antumor/anti-angiogenic -
A4237 Amuvatinib (MP-470, HPK 56)Summary: Tyrosine kinase inhibitor -
A2612 MG-1151 CitationTarget: ProteasomeSummary: Potent reversible proteasome inhibitor -
A4303 GSK3787Summary: PPARβ/δ antagonist,novel and irreversible -
A4323 Vardenafil HCl TrihydrateTarget: Phosphodiesterases (PDEs)Summary: PDE5 inhibitor, potent and selective -
A4341 ApixabanSummary: Factor Xa inhibitor

